This article is based on Mayo Clinic’s content.

What is metabolic syndrome (MetS)?

Metabolic syndrome is a group of serious disorders, including increased blood pressure, high blood sugar, excess body fat around the waist and abnormal levels of cholesterol or triglycerides – that occur simultaneously, increasing the risk of heart disease, stroke, aneurysm, deep vein thrombosis and diabetes among others.

Having just one of these disorders does not mean having metabolic syndrome. But any of these disorders increase the risk of incurring a serious illness. Having more than one of these disorders can raise your risk substantially.

If you have metabolic syndrome or any of its components, profound changes in lifestyle can delay or even prevent the occurrence of serious health problems.

Do you want to know more about the metabolic syndrome?
We recommend that you continue reading Conditions page of the NHS for the public.

Do you want to know more about the metabolic syndrome?

We recommend that you continue reading Conditions page of the NHS for the public.

What mushrooms have useful properties in hypertension?


Shown to reduce levels of cholesterol, triglycerides and phospholipids (fats).

Several studies show that in diets rich in fats, Maitake decreases cholesterol levels, triglycerides and lipid to values ​​close to those of groups with normal diet.

In relation to body weight, Maitake reduces the accumulation of lipids (fats) in the body. Also the results in lipid levels in the liver suggest that Maitake improves fat metabolism.


Combats the accumulation of fat and reduces triglyceride levels
Their unique compounds have shown to reduce obesity

This mushroom is also able to combat the accumulation of fat, reduce triglyceride levels and and regulate body weight gain. It would thus prevent the formation of atheromas in the blood vessels, acting positively against cardiovascular pathologies.


Reduces triglyceride levels and increases HDL cholesterol  levels
Reishi reduces triglyceride levels and increases HDL cholesterol levels in those with high cholesterol levels and hypertension, thus improving disease ris and factors associated with obesity. It generally also has shown to reduce cardiovascular risk. The capacities of Reishi polysaccharide extract also extend to the reduction of triglyceride (fat) concentration.


  1. Zhou S, Liu Y, Yang Y, Tang Q, Zhang J (2015) Hypoglycemic activity of polysaccharide from fruiting bodies of the Shaggy Ink Cap medicinal mushroom, Coprinus comatus (Higher Basidiomycetes), on mice induced by alloxan and its potential mechanism. International Journal of Medicinal Mushrooms 17, 957-964.
  2. Batra P, Sharma AK, Khajuria R (2013) Probing Lingzhi or Reishi medicinal mushroom Ganoderma lucidum (higher Basidiomycetes): a bitter mushroom with amazing health benefits. International Journal of Medicinal Mushrooms 15, 127-143.
  3. Sato M, Tokuji Y, Yoneyama S, Fujii-Akiyama K, Kinoshita M, Chiji H, Ohnishi M (2013) Effect of dietary maitake (Grifola frondosa) mushrooms on plasma cholesterol and hepatic gene expression in cholesterol-fed mice. Journal of Oleo Science 62, 1049-1058.
  4. Li F, Zhang Y, Zhong Z (2011) Antihyperglycemic effect of Ganoderma lucidum polysaccharides on streptozotocin- induced diabetic mice. International Journal of Molecular Science 12, 6135-6145.
  5. Oluba OM, Onyeneke EC, Ojieh GC, Idonije BO (2010) Evaluation of the hypoglycemic effect of aqueous extract of Ganoderma lucidum on STZ-induced diabetic Wistar rats. Annals of Biological Research 1, 41-49.
  6. Ding Z, Lu Y, Lu Z, Lv F, Wang Y, Bie X, Wang F, Zhang K (2010) Hypoglycaemic effect of comatin, an antidiabetic substance separated from Coprinus comatus broth, on alloxan-induced-diabetic rats. Food Chemistry 121, 39-43.
  7. Palomer X, Pérez A, Blanco-Vaca F (2005) Adiponectina: un nuevo nexo entre obesidad, resistencia a la insulina y enfermedad cardiovascular. Medicina Clínica 124, 388-395.
  8. Berger A, Rein D, Kratky E, Monnard I, Hajjaj H, Meirim I, Piguet-Welsch C, Hauser J, Mace K, Niederberger P (2004). Cholesterol-lowering properties of Ganoderma lucidum in vitro, ex vivo, and in hamsters and minipigs. Lipids in Health Disease 3.
  9. Bisen PS, Baghel RK, Sanodiya BS, Thakur GS, Prasad GBKS (2010) Lentinus edodes: A macrofungus with pharmacological activities. Current Medicinal Chemistry 17, 2419-2430.
  10. Hajjaj H, Mace C, Roberts M, Niederberger P, Fay LB (2005) Effect of 26-oxygenosterols from Ganoderma lucidum and their activity as cholesterol synthesis inhibitors. Applied and Environmental Microbiology 71, 3653-3658.
  11. Wasser SP (2005) Shiitake (Lentinus edodes). En: Encyclopedia of dietary supplements. Marcel Dekker, New York (USA), pp 653-664.
  12. Gao Y, Lan J, Dai X, Ye J and Zhou SH (2004) A phase I/II study of Ling Zhi mushroom Ganoderma lucidum extract in patients with type II diabetes mellitus. International Journal of Medicinal Mushrooms 6, 33-39.
  13. Hong L, Xun M, Wutong W (2007) Anti-diabetic effect of an a-glucan from fruit body of maitake (Grifola frondosa) on KK-Ay mice. Journal of Pharmacy and Pharmacology 59, 575-582.
  14. Horio H, Ohtsuru M (2001) Maitake (Grifola frondosa) improve glucose tolerance of experimental diabetic rats. Journal of Nutritional Science and Vitaminology 47, 57-63.
  15. Hsu CH, Liao YL, Lin SC, Hwang KC, Chou P (2007) The mushroom Agaricus Blazei Murill in combination with metformin and gliclazide improves insulin resistance in type 2 diabetes: a randomized, double-blinded, and placebo-controlled clinical trial. Journal of Alternative and Complementary Medicine 13, 97-102.
  16. Kabir Y, Kimura S (1989) Dietary mushrooms reduce blood pressure in spontaneously hypertensive rats (SHR). Journal of Nutritional Science and Vitaminology 35, 91-94.
  17. Kim MY, Park MH, Kim GH (1997) Effects of mushroom protein–bound polysaccharide on the blood glucose levels and energy metabolism in Streptozotocin- induced diabetic rats. Korean Journal of Nutrition 30, 743-750.
  18. Komoda Y, Shimizu M, Sonoda Y, Sato Y (1989) Ganoderic acid and its derivatives as cholesterol synthesis inhibitors. Chemical and Pharmaceutical Bulletin 37, 531-533.
  19. Kudo K, Nanba H. 1997. Anti-hyperliposis effect of Maitake fruit body (Grifola frondosa) 1. Bio Pharm Bull Effects of Administration of Grifola frondosa on Diabetic Rats 63 20: 781-785.
  20. Kabir Y, Kimura S, Tamura T (1988) Dietary effect of Ganoderma lucidum mushroom on blood pressure and lipid levels in spontaneously hypertensive rats (SHR). Journal of Nutritional Science and Vitaminology 34, 433-438.
  21. Hikino H, Ishiyama M, Suzuki Y, Konno C (1989) Mechanisms of hypoglycemic activity of ganoderan B: a glycan of Ganoderma lucidum fruit bodies. Planta Medica 55, 423-428.
  22. Hikino H, Konno C, Mirin Y, Hayashi T (1985) Isolation and hypoglycaemic activity of ganoderans A and B, glycans of Ganoderma lucidum fruit bodies. Planta Medica 51, 339-340.
  23. Kabir Y, Yamaguchi M, Kimura S (1987). Effect of shiitake (Lentinus edodes) and maitake (Grifola frondosa) mushrooms on blood pressure and plasma lipids of spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo) 33(5):341-6.
  24. Kaneda T, Tokuda S (1966) Effect of various mushroom preparations on cholesterol levels in rat. Journal of Nutrition 90, 371-376.
  25. Suzuki S, Ohshima S (1976) Influence of Shii-ta-ke (Lentinus edodes) on human serum cholesterol. Mushroom Science 9, 463-467.
  26. Tokita F, Shibukawa N, Yasumoto T, Kaneda T (1972) Isolation and chemical structure of the plasma-cholesterol reducing substance from Shiitake mushroom. Mushroom Science 8, 783-788.
  27. Zhang HN, Lin ZB (2004) Hypoglycemic effect of Ganoderma lucidum polysaccharides. Acta Pharmacologica Sinica 25, 191-195..
  28. Chibata I, Okumura K, Takeyama S (1969) Lentinacin: A new hypocholesterolemic substance in Lentinus edodes. Experientia 25, 1237-1238.